Early versions of blood pumping devices, most containing silicone rubber blood sacs, experienced major 3. Thromboembolism problems with thrombosis.
[4] Dacron-flocked surfaces were promulgated as a solution, the theory being that the Thromboembolism and infection are the most frequently formation of a 'pseudo-intimal' lining on these devices cited major complication associated with these blood would be non-thrombogenic [5] . Early efforts with texpumping devices [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . The Thermo Cardio Systems tured surfaces resulted in impaired diaphragm flexibility, Heart Mate 1000 IP left ventricular assist device (LVAD) hemolysis, and embolization [6] , but these problems seem (a textured-surface device) was used in 57 patients in 11 to have been resolved in the more modern devices. A different clinical centers and resulted in thromboembolic major breakthrough in materials was made with the cerebrovascular complications in only two patients [21] . introduction of segmental polyurethanes in 1967. That led Another series using this same device reported results on to adoption of this 'smooth' material for almost all devices 223 patients with only six suffering thromboembolic [7] . Problems related to blood sac calcification, soft tissue events [22] . A different group of investigators, using this pannus at the atrial cuff, and major thrombosis problems same device, found minimal thromboembolic complicawere gradually resolved with the introduction of low tions despite the absence of anticoagulation. However they profile valves, and a host of iterative improvements in found evidence of significant thrombin generation and fibrinolysis. They concluded their patients demonstrated obtained, from fourteen patients, from the left middle and was found to be normal when compared to controls cerebral artery, for a duration of 30 min per study. One [26] . Radioisotope labeled autologous platelets have been patient who suffered a fatal stroke averaged 0.03 / min high used to quantify platelet sequestration and organ micro intensity transient signals (HITS). The 13 asymptomatic embolism in prosthetic valve implantation studies, but this patients registered an average of 0.016 HITS / min [11] .
technology has apparently not been used to evaluate these That would translate to about 0.8 HITS per day, on problems in blood pumping devices to date [27] . average. Another study using this technique but using Recent advances in our understanding of host / materials different blood pumping devices recorded ten ischemic interactions should lead to easier and more useful methods cerebrovascular events and two peripheral thromboembolic of evaluating blood pumping devices for potential probevents during multiple observation periods in six patients.
lems. The antigen CD62, also called GMP-140 or PAD-HITS were found in 143 of 170 (84.1%) monitoring GEM, is a glycoprotein exposed on the external surface of periods ranging from 30 min to 3 h [10] .
platelets after platelet activation. Using flow cytometry and Molecular biology techniques were used to study the immunohistochemical techniques CD62 has been used to pseudo-intima formed on 11 textured surface devices quantify numbers of activated platelets in ventricular assist following explantation. No clinical thromboembolic events device patients [28] . Flow cytometry has also been used to had been reported from these patients. The pseudo-intima demonstrate that macrophages are activated by exposure to was composed of patches of cellular tissue intermingled foreign surfaces [29] . with areas of compact fibrinous material and islands of
The role the white blood cell population plays in adverse collagenous tissue containing fibroblast-like cells. Many of responses to cardiovascular devices remains to be comthe latter cells contained micro filaments with dense bodies pletely elucidated. We do know that both cellular and suggestive of myofibroblasts [18] . From what we know molecular responses are initiated when these devices are about initiation of the thrombosis cascade this is not a implanted. As a result of these responses protein biofilms description of a non-thrombotic surface [24] . RNA hybridare deposited on the foreign material surfaces. These ization analysis of this surface demonstrated that the protein biofilms include an increasingly long list of colonizing cells actively expressed genes encoding fibroadhesion molecule proteins that have been shown to nectin, actin, and types I and III collagen, all known interact with white blood cells, particularly polymorphonuactivators of thrombosis [18] .
clear cells, but also with lymphocytes and platelets [30] . The critical issue seems to be the definition of thromboProtein biofilms may also provide hospitable sites for embolism. In most patient studies the end-point seems to infectious agents to attach and grow as well as being be clinical neurological, renal or hepatic signs of thromsequestered from antimicrobial therapy. As the successful boembolic disease. Reports of definitive studies with use of these devices increases the incidence of infection significant numbers relating to platelet turn-over times, or related problems seems to be increasing. The mechanistic other indications of thrombotic activity, are difficult to details of how these protein biofilms enhance or limit long find. Autopsy results on patients seem to be limited to a term function of these devices needs careful and systematic search for macroscopic lesions with little evidence of the study. intensive serial sectioning and microscopic examination of target organs that would be required to identify and quantitate micro embolic lesions. There is a report on one References patient supported with a total artificial heart (TAH) for 185 days, who then received a successful heart transplant. large battery of coagulation tests and was also subjected to with LVADs. Platelet survival was found to be significantly 
